Iqvia Holdings (IQV) Total Current Liabilities (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Total Current Liabilities came in at $8.8 billion in Q2 2026, up 16.42% year-over-year from $7.6 billion in Q2 2025, and up 5.84% quarter-over-quarter from $8.3 billion in Q1 2026.
Analysis
Iqvia Holdings (IQV) Total Current Liabilities (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Total Current Liabilities across 15 years of filings, most recently posting $8.8 billion for Q2 2026.
- In Q2 2026, Total Current Liabilities rose 16.42% year-over-year to $8.8 billion; the TTM figure through Jun 2026 stood at $8.8 billion (up 16.42% YoY), while the FY2025 annual figure was $8.3 billion, up 19.85% from the prior year.
- Total Current Liabilities came in at $8.8 billion for Q2 2026 at Iqvia Holdings, up from $8.3 billion in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $8.8 billion in Q2 2026 to a low of $5.1 billion in Q2 2022.
- Average Total Current Liabilities over 5 years is $6.8 billion, with a median of $6.6 billion recorded in 2023.
- Year-over-year, Total Current Liabilities gained 29.09% in 2023 and slipped 3.14% in 2024.
- Over 5 years, Total Current Liabilities stood at $5.6 billion in 2022, then rose by 16.37% to $6.5 billion in 2023, then gained by 7.18% to $7.0 billion in 2024, then advanced by 19.85% to $8.3 billion in 2025, then advanced by 5.72% to $8.8 billion in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $8.8 billion in Q2 2026, $8.3 billion in Q1 2026, and $8.3 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 8.82 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 1.44 Bn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 3.93 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 1.13 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 963.70 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 363.19 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 72.74 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 18.73 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 4.76 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 1.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.82 Bn |
| Mar 31, 2026 | 8.33 Bn |
| Dec 31, 2025 | 8.34 Bn |
| Sep 30, 2025 | 8.51 Bn |
| Jun 30, 2025 | 7.57 Bn |
| Mar 31, 2025 | 7.18 Bn |
| Dec 31, 2024 | 6.96 Bn |
| Sep 30, 2024 | 6.99 Bn |
| Jun 30, 2024 | 6.62 Bn |
| Mar 31, 2024 | 6.45 Bn |
| Dec 31, 2023 | 6.49 Bn |
| Sep 30, 2023 | 6.59 Bn |
| Jun 30, 2023 | 6.54 Bn |
| Mar 31, 2023 | 6.66 Bn |
| Dec 31, 2022 | 5.58 Bn |
| Sep 30, 2022 | 5.25 Bn |
| Jun 30, 2022 | 5.10 Bn |
| Mar 31, 2022 | 5.16 Bn |
| Dec 31, 2021 | 5.24 Bn |
| Sep 30, 2021 | 4.85 Bn |